Drägerwerk stock: Dräger targets EUR 4.5 billion sales by 2030
Published on 11/18/2026 at 17:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGrowth and margin roadmap
- Dräger is combining integrated medical solutions with recurring revenue from its installed equipment base.
- The safety division is targeting selected growth markets including US fire departments, defense, maritime applications and cleantech.
- Management plans to support profitability through pricing, productivity gains and disciplined capital allocation.
At its Capital Markets Day in Lübeck on Wednesday, November 18, 2026, Drägerwerk said it is targeting net sales of EUR 4.5 billion by 2030, up EUR 1 billion from 2025. The company aims for an EBIT margin of 10% to 12%, compared with 6.7% in 2025, according to EQS News.
Growth plans across both divisions
Dräger's medical division plans to expand integrated solutions, patient monitoring and recurring revenue from its installed equipment base. The company is also focusing on growth in the United States and Asia-Pacific, while Europe remains an important base.
In safety technology, Dräger is concentrating on US fire departments, defense, maritime applications, energy transition and cleantech. The plan also calls for broader market access in the United States and Asia-Pacific, supported by technology and innovation.
Margin plan and capital allocation
Management expects higher gross margins and a slower increase in functional expenses to support profitability. Pricing, direct-cost optimization and productivity improvements are central levers, with more efficient development, sales and administrative processes also contributing.
Dräger intends to protect its balance sheet and prioritize financial stability and high-return organic investment. Selective acquisitions may complement the strategy, while the company plans to continue distributing at least 30% of net profit to shareholders.
Execution becomes the next focus
For investors, the strategy shifts attention from the medium-term targets to execution in both divisions. The medical business must translate integrated offerings and recurring revenue into stronger profitability, while safety technology is expected to scale in its selected growth markets.
The Capital Markets Day was scheduled for a live broadcast from 10:15 a.m. to approximately 2:30 p.m. Central European time. Dräger said a recording and the Executive Board presentations would be made available on its Investor Relations website.
For the broader German market, see Current market reports.
More news and analyses on Drägerwerk stock.
Drägerwerk at a glance
- Company: Drägerwerk AG & Co. KGaA
- ISIN: DE0005550636 preferred shares
- Business: Medical and safety technology
- Capital Markets Day: November 18, 2026, Lübeck
